Suppr超能文献

碘-131治疗会引发甲状腺癌风险吗?(作者译)

[Thyroid cancer risk from iodine-131-treatment? (author's transl)].

作者信息

Creutzig H, Hundeshagen H

出版信息

Med Klin. 1977 May 13;72(19):855-7.

PMID:865388
Abstract

Six of 240 patients with thyroid carcinoma had a history of 131I treatment for a benign disease. All patients had underwent a total thyroidectomy. In this 2.5% of our cancer patients a tumor induction by radiation might be po-sible. The six cases are described in detail and the literature is revieved. A longer observation period than 30 years will be necessary to exclude an increase in prevalence of thyroid carcinomas after 131I treatment in the adult. The clinical importance of this possible increase will dubious; the thyroid carcinoma prevalence in a nonendemic goitre region has been estimated with 5--6%. On the other hand an increase in development of "benign" thyroid nodules has been seen after 131I treatment of thyrotoxicosis. Therefore not every younger hyperthyroid patient should be treated in this manner.

摘要

240例甲状腺癌患者中有6例曾因良性疾病接受过131I治疗。所有患者均接受了甲状腺全切除术。在我们这2.5%的癌症患者中,辐射诱发肿瘤是有可能的。详细描述了这6例病例并回顾了相关文献。要排除成人接受131I治疗后甲状腺癌患病率增加的可能性,需要超过30年的更长观察期。这种可能增加的临床重要性尚不确定;在非地方性甲状腺肿地区,甲状腺癌的患病率估计为5%-6%。另一方面,在对甲状腺毒症进行131I治疗后,已观察到“良性”甲状腺结节的发生率有所增加。因此,并非每个年轻的甲亢患者都应以这种方式治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验